M12 Stock Overview
Provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, Hungary, Bulgaria, Romania, and Australia. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
M1 Kliniken AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €16.85 |
| 52 Week High | €22.70 |
| 52 Week Low | €8.92 |
| Beta | 1.17 |
| 11 Month Change | 2.12% |
| 3 Month Change | 20.36% |
| 1 Year Change | 86.39% |
| 33 Year Change | 132.73% |
| 5 Year Change | 25.75% |
| Change since IPO | 236.73% |
Recent News & Updates
Recent updates
Shareholder Returns
| M12 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 1.8% | 0.3% | -1.3% |
| 1Y | 86.4% | 15.7% | 7.4% |
Return vs Industry: M12 exceeded the German Healthcare industry which returned 14.5% over the past year.
Return vs Market: M12 exceeded the German Market which returned 7.1% over the past year.
Price Volatility
| M12 volatility | |
|---|---|
| M12 Average Weekly Movement | 7.0% |
| Healthcare Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: M12's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: M12's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 219 | Attila Strauss | www.m1-kliniken.de |
M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, Hungary, Bulgaria, Romania, and Australia. It operates in two segments, Beauty and Trade. The Beauty segment provides aesthetic surgery services, such as breast augmentation, eyelid lifts, and liposuction; and other aesthetic medical treatment services, including injections with hyaluronic acid and botulinum toxin.
M1 Kliniken AG Fundamentals Summary
| M12 fundamental statistics | |
|---|---|
| Market cap | €300.59m |
| Earnings (TTM) | €16.76m |
| Revenue (TTM) | €333.27m |
17.9x
P/E Ratio0.9x
P/S RatioIs M12 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| M12 income statement (TTM) | |
|---|---|
| Revenue | €333.27m |
| Cost of Revenue | €293.68m |
| Gross Profit | €39.59m |
| Other Expenses | €22.83m |
| Earnings | €16.76m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.90 |
| Gross Margin | 11.88% |
| Net Profit Margin | 5.03% |
| Debt/Equity Ratio | 8.5% |
How did M12 perform over the long term?
See historical performance and comparison